NOVASTERILIS, INC.

Medtech · Private

Supercritical carbon dioxide sterilization platform (NovaAPI) for pharmaceutical APIs and drug products using NovaKill sterilant

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · novasterilis.com

Sector: Medtech
Total capital: $3.8M

Federal grants: $3.8M; 7 awards · 2015–2024; Rank in peer group#8 of 16
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 3 pending · first 2017; Rank in peer group#5 of 16

Capital timeline

Latest events

Dec 2024Federal grantHealth and Human S · Phase II · NovaAPI: Terminal Sterilization of Drug Substances and Products$893K
Jan 2024Federal grantHealth and Human S · Phase II · NovaAPI: Terminal Sterilization of Drug Substances and Products$861K
Jul 2022Federal grantHealth and Human S · Phase II · NovaAPI: Terminal Sterilization of Drug Substances and Products$242K
Dec 2017Federal grantHealth and Human S · Phase II · Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$432K
Jan 2017Federal grantHealth and Human S · Phase II · Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$1M
Jul 2015Federal grantHealth and Human S · Phase I · Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization$141K
Feb 2015Federal grantHealth and Human S · Phase I · Sporocidal Mechanism and Inline Monitoring of Peracetic Acid in Supercritical CO2$147K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 16 peers

Line = median

Medtech · System

Federal grants#8 · top 50%
Granted patents#5 · top 31%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 5

Feb 10, 2026GrantedTreatment Of Elastomeric Materials With Supercritical CO2USPTOUS 12,545,770
May 23, 2017GrantedMethod And Apparatus For The Sterilization Of Ground Meat Using Supercritical CO2USPTOUS 9,655,373
Apr 27, 2017PendingAnchoring and/or Impregnation of Biological Vehicles with Cargo Molecules using a Subcritical or Supercritical FluidUSPTOApplication 15332572

Show all 5 patent records

Treatment Of Elastomeric Materials With Supercritical CO2Feb 10, 2026 · US 12,545,770Granted
Method And Apparatus For The Sterilization Of Ground Meat Using Supercritical CO2May 23, 2017 · US 9,655,373Granted
Anchoring and/or Impregnation of Biological Vehicles with Cargo Molecules using a Subcritical or Supercritical FluidApr 27, 2017 · Application 15332572Pending
Inactivating Organisms Using Carbon Dioxide At Or Near Its Supercritical Pressure And Temperature ConditionsApplication PCTUS2004020152Pending
Sterilization Methods And Apparatus Which Employ Additive-containing Supercritical Carbon Dioxide SterilantApplication PCTUS2004019242Pending

ENCLEAR THERAPIES, INC.Similar federal contract value in Medtech · null in contracts
APC AVE 20, LLCSimilar federal contract value in Medtech · null in contracts
BIOVIDRIA, INC.Similar federal contract value in Medtech · null in contracts
VIC FOUNDRY INCSimilar federal contract value in Medtech · null in contracts
Revelle Aesthetics, Inc.Similar federal contract value in Medtech · null in contracts
VST Operating Corp.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.